Contributions of AmylinAmos

Contributions by AmylinAmos, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 6,249 edits includes activity predating the current log.

1. 06:34, 9 Mar 2026 (diff | hist) Beyond-use date 23,171 ±0 m expand §Assignment in the absence of data
2. 02:07, 10 Jan 2026 (diff | hist) Enteroendocrine L cell 5,083 ±0 fix unit
3. 22:17, 26 Aug 2025 (diff | hist) Shanghai Wibson Biotechnology 7,778 ±0 rm citation to a supplier's own page
4. 04:05, 22 Jun 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 2,486 +336 add citation for the incidence figure
5. 16:40, 7 Jun 2025 (diff | hist) Tianjin Finder Chemical 7,687 ±0 m add figure
6. 06:37, 9 May 2025 (diff | hist) Enteroendocrine L cell 4,648 ±0 m reorder sections to follow the class template
7. 00:52, 11 Mar 2025 (diff | hist) Glucagon-like peptide-1 10,239 ±0 m add see also
8. 05:10, 11 Dec 2024 (diff | hist) Incretin effect 4,982 ±0 m add PMID
9. 02:24, 13 Nov 2024 (diff | hist) Incretin effect 4,860 ±0 m split section
10. 13:51, 26 Sep 2024 (diff | hist) Incretin effect 4,049 ±0 split section
11. 11:19, 26 Aug 2024 (diff | hist) Wuhan Wansheng Biotechnology 4,394 ±0 rm citation to a supplier's own page
12. 05:17, 6 Jul 2024 (diff | hist) Glucagon-like peptide-1 3,005 +1,519 add confidence interval